Therapeutic applications of ATP-(P2)-receptors agonists and antagonists

Bibliography

• BURNSTOCK G: Purinergic nerves. Pharmacol. Rev. (1972) 24:509–581.
   PubMed Web of Science ®Google Scholar
• KING BF, TOWNSEND-NICHOLSON A, BURNSTOCK G: Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors. Trends Pharmacol. ScL (1998) 19:506–514.
   PubMedGoogle Scholar
• STONE TW, SIMMONDS HA: Purines: Basic and ClinicalAspects. Kluwer Academic Publishers, MA, USA (199 0:1–245.
   Google Scholar
• CHAN CM, UNWIN RJ, BURNSTOCK G: Potential func-tional roles of extracellular ATP in kidney and urinary tract. Exp. Nephrol. (1998) 6:200–207.
   PubMedGoogle Scholar
• BOARDER MR, HOURANI SMO: The regulation of vascu-lar function by P2 receptors: multiple site and multiple receptors. Trends Pharmacol Sci. (1998) 19:99–107.
   PubMedGoogle Scholar
• BARNARD EA, SIMON J, WEBB TE: Nucleotide receptors in the nervous system - an abundant component using diverse transduction mechanisms. Mol. Neurobiol. (1997) 15:103–129.
   PubMedGoogle Scholar
• INOUE K: The function of ATP receptors in the hippo-campus. Pharmacol. Res. (1998) 38:323–331.
   PubMedGoogle Scholar
• ABBRACHIO MP: P1 and P2 receptors in cell growth and differentiation. Drug Dev. Res. (1996) 39:393–406.
   Google Scholar
• SPEDDING M, WILLIAMS M: Development in purine and pyrimidine receptors based therapeutics. Drug Dev. Res. (1996) 39:436–441.
   Web of Science ®Google Scholar
• ABBRACCHIO MP, BURNSTOCK G: Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharma-col. Ther. (1994) 64:445–475.
   Google Scholar
• BARNARD EA, BURNSTOCK G, WEBB TE: The G-protein coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol. ScL (1994) 15:67–70.
   PubMed Web of Science ®Google Scholar
• BURNSTOCK G: P2-purinoceptors: localization, func-tion and transduction mechanisms. Ciba Foundation Symposium. John Wiley, Chichester, UK (1996).
   Google Scholar
• ZIMMERMAN H: Signalling via ATP in the nervous sys-tem. Trends Neurosci. (1994) 17:420.
   PubMedGoogle Scholar
• HARDEN TK, BOYER JL, NICHOLAS RA: P2-purinergic re-ceptors subtype-associated signalling responses and structure. Ann. Rev. Pharmacol Toxicol (1995) 35:451.
   Google Scholar
• ERB L, GARRAD R, WANG Y et al.: Site directed muta-genesis of P2U purinoceptors. J. Biol. Chem. (1995) 270:4185–4188.
   PubMedGoogle Scholar
• JIANG Q, GUO D, LEE BX et al: A mutational analysis of residues essential for ligand recognition at the human P2Y1-receptor. Mol. Pharmacol. (1997) 59:499–507.
   Google Scholar
• VAN RHEE MA, FISCHER B, VAN GALEN PGM, JACOBSON KA: Modelling the P2Y purinoceptor using rhodopsin as template. Drug Design Disc. (1995) 13:133–154.
   PubMedGoogle Scholar
• MORO S, GUO D, CAMAIONI E, BOYER JL, HARDEN TK, JACOBSON KA: Human P2Yi-receptor: molecular mod-eling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J. Med. Chem. (1998) 41:1456–1466.
   PubMedGoogle Scholar
• SIDDIQI SM, SHAVER SR, PENDERGAST W et al.: Molecu-lar modeling of the P2Y2 purinoceptor and synthesis of selected ligands. Drug Dev. Res. (1998) 43:33.
   Google Scholar
• BHAGWAT SS, WILLIAMS M: P2 purine and pyrimidine receptors: emerging superfamilies of G-protein and ligand-gated ion channels receptors. Eur. J. Med. Chem. (1997) 32:183–193.
   Google Scholar
• ••A thorough review of P2-Rs.
   Google Scholar
• ABBRACCHIO MP, BURNSTOCK G: Purinergic signal-ling: pathophysiological roles. Jpn. J. Pharmacol. (1998) 78:113–145.
   PubMedGoogle Scholar
• ••A review focusing on distribution and physiological roles ofP2-Rs.
   Google Scholar
• FREDHOLM BB, BURNSTOCK G, HARDEN TK, SPEDDING M: P2-receptor nomenclature. Drug Dev. Res. (1996) 39:461–466.
   Google Scholar
• BRAKE AJ, WAGENBACH MJ, JULIUS D: New structural motif for ligand gated ion channels defined by iono-tropic ATP receptor. Nature (1994) 371:519–523.
   PubMed Web of Science ®Google Scholar
• COLLO G, NORTH RA, KAWASHIMA E et al.: Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J. NeuroscL (1996) 16:2495–2507.
   PubMed Web of Science ®Google Scholar
• •A comprehensive comparison of P2X-R subtypes.
   Google Scholar
• VALERA S, TALABOT F, EVANS RJ et al.: Characterization and chromosomal localization of a human P2X recep-tor from the urinary bladder. Recept. Channels (1995) 3 :283–289.
   PubMedGoogle Scholar
• LONGHURST PA, SCHWEGEL T, FOLANDER K et al.: The human P2X1 receptor: molecular cloning, tissue distri-bution, and localization to chromosome 17. Biochem. Biophys. Acta (1996) 1308:185–188.
   PubMedGoogle Scholar
• DHULIPALA PDK, WANG Y-X, KOTLIKOFF MI: The hu-man P2X4 receptor gene is alternatively spliced. Gene (1998) 207:259–266.
   PubMedGoogle Scholar
• CHEN CC, AKOPIAN AN, SIVILLOTI L, COLQUHOUN D, BURNSTOCK G, WOOD JN: A P2X receptor expressed by a subset of sensory neurons. Nature (1995) 377:428–431.
   PubMed Web of Science ®Google Scholar
• GRACIA-GUZMAN M, STUHMER W, SOTO F: Molecular characterization and pharmacological properties of the human P2X3 purinoceptor. Mol. Brain Res. (1997) 47:59–66.
   PubMedGoogle Scholar
• GRACIA-GUZMAN B, SOTO F, LAUBE B et al.: Molecular cloning and functional expression of a novel rat heart P2X purinoceptor. FEBS Lett. (1996) 388:123–127.
   PubMedGoogle Scholar
• BOX, ZHANG Y, NASSAR M, BURNSTOCK G, SCHOEPFER R: A P2X purinoceptor cDNA conferring a novel phar-macological profile. FEBS Lett. (1995) 375:129–133.
   PubMedGoogle Scholar
• RASSENDREN F, BUELL GN, VIRGINIO C et al: The per-meabilizing ATP receptor, P2X7. Cloning and expres-sion of a human cDNA. J. Biol. Chem. (1997) 272:5482–5486.
   PubMed Web of Science ®Google Scholar
• SOUTHEY MC, HAMMET F, HUTHCHINS AM et al: Mo-lecular cloning and sequencing of a novel human P2 nucleotide receptor. Biochem. Biophys. Acta (1996) 1309:77–80.
   PubMedGoogle Scholar
• JASSENS R, COMMUNI D, PIROTTON S et al.: Cloning and tissue distribution of the human P2Y7 receptor. Bio-chem. Biophys. Res. Comm. (1996) 221:588–593.
   PubMedGoogle Scholar
• LEON C, HECHLER B, VIAL C, LERAY C et al.: The P2Y7 re-ceptor is an ADP receptor antagonized by ATP and ex-pressed in platelets and megakaryoblastic cells. FEBS Lett. (1997) 403:26–30.
   PubMed Web of Science ®Google Scholar
• LEON C, VIAL C, CAZENAVE J-P et al.: Cloning and se-quencing of a human cDNA encoding endothelial P2Y1 purinoceptor. Gene (1996) 171:295–297.
   PubMed Web of Science ®Google Scholar
• PARR CE, SULLIVAN DM, PARADISO AM et al.: Identifica-tion and cloning of a human P2U purinoceptor a target for cystic fibrosis pharmacotherapy. Proc. Natl. Acad. Sci. USA (1994) 91:3275–3279.
   PubMed Web of Science ®Google Scholar
• WEBB TE, HENDERSON D, KING BF et al.: A novel G-protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates. Mol Phar-macol. (1996) 50:258–265.
   PubMed Web of Science ®Google Scholar
• NICO JS, KLOMP J, VAN DE HEUVEL M et al.: Molecular cloning and characterization of a novel orphan recep-tor (P2p) expressed in human pancreas that shows high structural homology to the P2U purinoceptor. FEBS Lett. (1996) 384:260–264.
   Google Scholar
• COMMUNI D, PIROTTON S, PARMENTIER M et al.: Clon-ing and functional expression of a human uridine nu-cleotide receptor. J. Biol. Chem. (1995) 270:30849–30852.
   PubMed Web of Science ®Google Scholar
• WEBB TE, KAPLAN MG, BARNARD EA: Identification of 6111 as a P2Y purinoceptor: P2Y5. Biochem. Biophys. Res. Comm. (1996) 219:105–110.
   PubMedGoogle Scholar
• COMMUNI D, PARMENTIER M, BOEYNAEMS J-M: Clon-ing, functional expression and tissue distribution of the human P2Y6 receptor. Biochem. Biophys. Res. Comm. (1996) 222:303–308.
   PubMed Web of Science ®Google Scholar
• AKBER GKM, DASARI VR, WEBB TE et al: Molecular clon-ing of a novel P2 purinoceptor from human erythro-leukemic cells. J. Biol. Chem. (1996) 271:18363–18367.
   PubMedGoogle Scholar
• BOGDANOV Y, DALE L, KING BF, WHITTOCK N, BURN-STOCK G: Early expression of a novel nucleotide re-ceptor in the neural plate of Xenopus embryos. J. Biol. Chem. (1997) 272:12583–12590.
   PubMed Web of Science ®Google Scholar
• FISCHER B, BOYER JL, HOYLE CHV et al.: Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether deriva-tives of adenosine 5'-triphosphate. J. Med. Chem. (1993) 36:3937–3946.
   PubMed Web of Science ®Google Scholar
• •Comprehensive SAR of adenine nucleotides at P2X-R and P2Y-R.
   Google Scholar
• BURNSTOCK G, FISCHER B, HOYLE CHV et al.: Structure activity relationship for derivatives of adenosine 5'-tr-iphosphate as agonists at P2-purinoceptors : heteroge-neity within P2X and P2Y subtypes. Drug Dev. Res. (1994) 31:206–219.
   PubMedGoogle Scholar
• •Comprehensive SAR of adenine nucleotides at P2X-R and P2Y-R.
   Google Scholar
• BOYER JL, O'TUEL JW, FISCHER B, JACOBSON KA, HARDEN TK: 2-Thioether derivatives of adenine nu-cleotides are exceptionally potent agonists at adenylyl cyclase-linked P2Y-purinoceptors. Br. J. Pharmcol. (1995) 116:2611–2616.
   PubMedGoogle Scholar
• ZIMMET J, JARLEBARK E, VAN GALEN PJM, JACOBSON KA, HEILBRONN E: Synthesis and biological activity of novel 2-thio derivatives of ATP. Nucleosides Nucleotides (1993) 12:1–20.
   PubMed Web of Science ®Google Scholar
• FISCHER B, HALBFINGER E, MAJOR DT, RITZMAN M, UBL JJ, REISER G: Molecular recognition of modified ade-nine nucleotides by the P2Y7-receptor. I. A synthetic, biochemical, and NMR approach. (Submitted).
   Google Scholar
• JACOBSON KA, FISCHER B, MAILLARD M et al: Adenosine and Adenine Nucleotides: from Molecular Biology to Inte-grative Physiology. Belardinelli L, Pelleg A (Eds.), Kluwer, MA, USA (1995):149.
   Google Scholar
• BURNSTOCK G, CUSACK NJ, MELDRUM LA: Effects of phosphorothioate analogues of ATP, ADP and AMP on guinea-pig taenia coli and urinary bladder. Br. J. Phar-macol. (1984) 82:369–374.
   PubMed Web of Science ®Google Scholar
• ECKSTEIN F, STERNBACH H: Nucleoside 5'4)--phosphorothioates as inhibitors for phosphatases. Biochim. Biophys. Acta (1967) 146:618–619.
   PubMedGoogle Scholar
• URI A, JARLEBARK L, VON KUGELGEN I, SCHONBERG T, UNDEN A, HEILBRONN E: A new class of compounds, peptide derivatives of adenosine 5'-carboxylic acid, in-cludes inhibitors of ATP receptor-mediated responses. Bioorg. Med. Chem. (1994) 2:1099–1105.
   PubMedGoogle Scholar
• JARLEBARK L, ERLANDSSON M, URI A et al.: Peptidyl con-jugates of adenosine 5'-carboxylic acid synthesized and evaluated as ligands for P2 purinoceptors. Bio-chem. Biophys. Res. Commun. (1996) 229:363–369.
   PubMedGoogle Scholar
• PEHK T, URI A: Synthesis and structural chracterization of conjugates of adenosine and tetra-aspartate, novel analogues of ATP. Bioorg. Med. Chem. Lett. (1997) 7:2159–2164.
   Google Scholar
• FISCHER B, YEFIDOFF R, MAJOR DT et al.: Characteriza-tion of mini-nucleotides as P2X-receptor agonists in rat cardiocytes culture. An integrated synthetic, bio-chemical and theoretical study. (Submitted).
   Google Scholar
• CAMAIONI E, BOYER JL, MOHAMRAM A, HARDEN TK, JA-COBSON KA: Deoxy adenosine bisphosphate deriva-tives as potent antagonists at P2Y7-receptors. J. Med. Chem. (1998) 41:183–190.
   PubMedGoogle Scholar
• •First P2Y1-R antagonist.
   Google Scholar
• DAMER S, NIEBEL B, CZECHE S, NICKEL P: NF279: a novel potent and selective antagonist of P2X-receptor medi-ated responses. Eur. J. Pharmacol. (1998) 350:R5–R6.
   Google Scholar
• JACOBSON KA, KIM Y-C, WILDMAN SS et al: A pyridox-ine cyclic phosphate and its 6-azoaryl derivative selec-tively potentiate and antagonize activation of P2X1 receptors. J. Med. Chem. (1998) 41:2201–2206.
   PubMedGoogle Scholar
• •First P2X1-R selective antagonist.
   Google Scholar
• VIRGINIO C, ROBERSTSON G, SURPRENANT A, NORTH RA: Trinitropheyl substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors. Mol. Pharmacol. (1998) 53:969–973.
   PubMed Web of Science ®Google Scholar
• •First P2X1-R and P2X3-R antagonists.
   Google Scholar
• LOUBATIERES-MARIAMI MM, CHAPAL J, LIGNON F, VAL-LET G: Structural specificity of nucleotides for insulin secretory action from the isolated perfused rat pan-creas. Eur. J. Pharmacol (1979) 59:277–286.
   PubMedGoogle Scholar
• HILLAIRE-BUYS D, BERTRAND G, CHAPAL J, PUECH R, RIBES G, LOUBATIERES-MARIAMI MM: Stimulation of in-sulin secretion and improvement of glucose tolerance in rat and dog by the P2Y-purinoceptor agonist, adeno-sine 5'-0-(2-thiodiphosphate). Br. J. Pharmacol (1993) 109:183–187.
   PubMedGoogle Scholar
• RIBES G, BERTRAND G, PETIT P, LOUBATIERES-MARIAMI MM: Effects of 2-methylthio ATP on insulin secretion in the dog in vivo. Eur. Pharmacol (1988) 155:171–174.
   PubMedGoogle Scholar
• PETIT P, HILLAIRE-BUYS D, MANTEGHETTI M, DEBRUS S, CHAPAL J, LOUBATIERES-MARIAMI MM: Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell. Br. J. Pharmacol (1998) 125:1368–1374.
   PubMedGoogle Scholar
• FISCHER B, SHAHAR L, SHULKIN A et al.: 2 - Thioether-5'-0-(1-thiotriphosphate) adenine deriva-tives as new insulin secretagogues acting through P2Y-receptors. (Submitted).
   Google Scholar
• CUSACK NJ, PETTEY CJ: Effects of phosphate modified analogs of adenosine 5'-diphosphate and adenosine 5'-triphosphate at P2T-purinoceptors mediating hu-man platelet activation by ADP. Drug. Dev. Res. (1996) 37:212–222.
   Google Scholar
• HOURANI SMO, WELFORD LA, CUSACK NJ: Effects of 2-methylthioadenosine 5'-8,y-methylenetriphospho-nate and 2-ethylthioadenosine 5'-monophosphate on human platelet activation induced by adenosine 5'-d-iphosphate. Drug. Dev. Res. (1996) 38:12–23.
   Google Scholar
• BENNETT WD, OLIVIER KN, ZEMAN KLHOHENKER KW, BOUCHER RC, KNOWELS MR: Effect of uridine 5'-tripho-sphate plus amiloride on mucociliary clearance in adult cystic fibrosis. Am. J. Res. Critical Care Med. (1996) 153:1796–1801.
   PubMed Web of Science ®Google Scholar
• PODRASKY E, XU D, LIANG BT: A novel phospholipase C-and cAMP-independent positive inotropic mecha-nism via a P2 purinoceptor. Am. J. Physiol. (Heart Circ. Physiol.) (1997) 42:H2380–H2387.
   Google Scholar
• NORENBERG W, LANGOSCH JM, GEBICKE-HAERTER PJ et al.: Characterization and possible function of adeno-sine 5'-triphosphate receptors in activated rat micro-glia. Br. J. Pharmacol (1994) 111:942–950.
   PubMed Web of Science ®Google Scholar
• SALTER MW, HICKS JL: ATP causes release of intracellu-lar Ca2+ via the phospholipase C/1P3 pathway in astro-cytes from the dorsal spinal cord. J. Neurosci. (1995) 15:2961–2971.
   PubMedGoogle Scholar